Mutations Associated With Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor in Vitro

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01228-07
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Early Onset of Autoimmune Disease by the Retroviral Integrase Inhibitor Raltegravir

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Prevalence of HIV-1 Integrase Mutations Related to Resistance to Dolutegravir in Raltegravir Naïve and Pretreated Patients

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2012English

Raltegravir: A Potent and Safe Integrase Inhibitor With a Favourable Impact on Cardiovascular and Liver Profile

Journal of the International AIDS Society
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2008English

Evidence That Raltegravir (Isentress, Merck), a Retroviral Integrase Inhibitor Is Effective Against Recurrent Human Herpes Simplex Virus Infection Associated With NK-cell Deficiency

Pediatrics & Therapeutics
2013English

Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing

Journal of Infectious Diseases
Infectious DiseasesAllergyImmunology
2012English

Performance of the Abbott RealTime HIV-1 Viral Load Assay Is Not Impacted by Integrase Inhibitor Resistance-Associated Mutations

Journal of Clinical Microbiology
Microbiology
2011English

A Long-Acting Formulation of the Integrase Inhibitor Raltegravir Protects Humanized BLT Mice From Repeated High-Dose Vaginal HIV Challenges

Journal of Antimicrobial Chemotherapy
Infectious DiseasesMicrobiologyPharmacology
2016English

In Vitro Screening for Genetic Signatures Associated With Sensitivity to Targeted Cancer Therapeutics

Science-Business eXchange
2013English

A Novel Approach to the Treatment of Acute Renal Failure Associated With Rhabdomyolysis

Intensive Care Medicine Experimental
Critical CareIntensive Care Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy